LNA Sante SA (FR:LNA) has released an update.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score a data driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
LNA Santé SA reported a robust first-half performance for 2024, with operating revenue increasing by 5.7% to €386.3 million and operating net result up by 5.1% to €15.0 million, demonstrating the company’s resilience amidst the SMR pricing reform impact. The company also highlighted a solid operating net margin of 3.9% and liquidity of €170 million, which will support future development and health challenges. These results are part of the success of the Grandir Ensemble 3 project and the dedication of their 9,000 professionals to quality care and patient satisfaction.
For further insights into FR:LNA stock, check out TipRanks’ Stock Analysis page.
